Financials
- Market Capitalization 1.72 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.3
Rapporto prezzo/fatturato
162.41
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2037 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.58 USD | -3.75% | +0.64% | +7.89% | -8.31% | 1.76 B USD | ||
| 2039 | SEPN Septerna, Inc. - Common Stock | 37.56 USD | -2.11% | -1.08% | -2.85% | +70.65% | 1.75 B USD | ||
| 2049 | NUVB Nuvation Bio Inc. Class A Common Stock | 4.90 USD | -2.00% | -1.01% | -16.95% | +34.25% | 1.72 B USD | ||
| 2060 | GPCR Structure Therapeutics Inc - American Depositary Shares | 23.91 USD | -6.38% | -13.21% | -38.57% | -10.58% | 1.71 B USD |